Free Newsletter
In breakthrough, mice produce human liver cells
A team of scientists at Oregon Health & Science University's school of medicine has engineered mice that produce human liver cells, a breakthrough that will offer researchers a significant advantage in testing new drugs. Because the liver is responsible for deconstructing the chemicals that enter the body, virtually all new drugs have to be tested to determine their impact on the liver--a key indicator of toxicity. Chemicals are often converted to new chemicals in the liver in completely unexpected ways, making the liver test critical to the success of any development program. In particular, the new mouse model will be able to test therapies that are known to mount fierce attacks on the human liver, including diseases like hepatitis C and malaria.
- check out the release
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: